0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Brief Reports |

Ranitidine-Induced Granulocytopenia: Recurrence with Cimetidine Administration

ALAN F. LIST, M.D.; DAVID H. BEAIRD, M.D.; and THOMAS KUMMET, M.D.
[+] Article and Author Information

▸Requests for reprints should be addressed to Alan F. List, M.D.; Section of Hematology/Oncology, Veterans Administration Medical Center, 7th and Indian School Road; Phoenix, AZ 85012.


Phoenix Veterans Administration Medical Center and Good Samaritan Medical Center, Phoenix, Arizona


Ann Intern Med. 1988;108(4):566-567. doi:10.7326/0003-4819-108-4-566
Text Size: A A A
This excerpt has been provided in the absence of an abstract.

Drug-induced granulocytopenia occurs infrequently with Cimetidine administration (1). Ranitidine hydrochloride, the newest H2-antagonist in use, has gained widespread application because of its longer dosing interval and relative lack of serious adverse reactions (2). We report a case of reversible, ranitidine-induced granulocytopenia with bone marrow findings simulating those of acute promyelocytic leukemia that recurred after Cimetidine was administered.

A 61-year-old white man was hospitalized with fever and granulocytopenia on 10 October 1986. Five months earlier a craniotomy was done with partial resection of a grade IV astrocytoma. Postoperatively, the patient received 5000 rad wholebrain irradiation and phenytoin therapy, 300 mg daily,

...

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles
Haematological adverse effects of histamine H2-receptor antagonists. Med Toxicol Adverse Drug Exp 1988 Nov-Dec;3(6):430-48.
Side effects of ranitidine. Drug Saf 1991 Mar-Apr;6(2):94-117.

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)